Rocket Pharmaceuticals (RCKT) Interest & Investment Income (2015 - 2026)
Rocket Pharmaceuticals (RCKT) posted Interest & Investment Income of $161000.0 for Q1 2026, down 76.67% sequentially from $690000.0 in Q4 2025, and down 87.95% YoY from $1.3 million in Q1 2025.
Rocket Pharmaceuticals (RCKT) Interest & Investment Income (2015 - 2026) Analysis & Trends
Rocket Pharmaceuticals has reported Interest & Investment Income for 12 years, with the latest figure at $161000.0 in Q1 2026.
- Quarterly Interest & Investment Income fell 87.95% year-over-year to $161000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 68.92% YoY) and the FY2025 annual result came in at $3.2 million, down 61.07% from the prior year.
- Interest & Investment Income fell to $161000.0 in Q1 2026 per RCKT's latest filing, from $690000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $3.0 million in Q1 2024 and troughed at $161000.0 in Q1 2026.
- A 5-year average of $1.2 million and a median of $1.2 million in 2022 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2026: Interest & Investment Income jumped 11250.0% in 2022, then slumped 87.95% in 2026.
- Over 5 years, Interest & Investment Income stood at $1.2 million in 2022, then sank by 34.62% to $814000.0 in 2023, then surged by 98.65% to $1.6 million in 2024, then tumbled by 57.33% to $690000.0 in 2025, then plunged by 76.67% to $161000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $161000.0, $690000.0, and $709000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Rocket Pharmaceuticals | 380.92 Mn | 380.92 Mn | - | 347,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 347,000.00 |
| Mar 31, 2026 | 161,000.00 |
| Dec 31, 2025 | 690,000.00 |
| Sep 30, 2025 | 709,000.00 |
| Jun 30, 2025 | 483,000.00 |
| Mar 31, 2025 | 1.34 Mn |
| Dec 31, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 3.03 Mn |
| Dec 31, 2023 | 814,000.00 |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 846,000.00 |
| Mar 31, 2023 | 1.91 Mn |
| Dec 31, 2022 | 1.25 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 669,000.00 |
| Mar 31, 2022 | 623,000.00 |
| Dec 31, 2021 | 850,000.00 |
| Sep 30, 2021 | 806,000.00 |